Cellular Dynamics Q4 Revenues up 45 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Cellular Dynamics said after the close of the market on Monday that its revenues for the fourth quarter increased 45 percent year over year.

The Madison, Wis.-based developer of fully functional human cells for research applications reported total revenues of $4.2 million for the three months ended Dec. 31, 2013, up from $2.9 million in the year-ago fourth quarter. Product sales rose 9 percent to $2.5 million from $2.3 million, while revenues from collaborations, partnerships, and other sources more than doubled to $1.7 million from $657,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.